🔎 Trials Near Me

Home › Rectal Cancer › New York

Rectal Cancer clinical trials in New York

22 studies for Rectal Cancer are looking for participants at sites in New York.

Cities in New York

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

  • Montefiore Medical Center-Einstein Campus, The Bronx
  • James J Peters VA Medical Center, The Bronx
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07283939

Family Communications After Genetic Testing

  • Glens Falls Hospital, Glens Falls
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07143487

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

  • Memorial Sloan Kettering Cancer Center ( Site 0095), New York
  • Ellis Hospital ( Site 0098), Schenectady
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06997497

A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy

  • Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07227636

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Columbia University, New York
  • NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

  • NYU Langone Health Perlmutter Cancer Center, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT07629960

Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

  • Memorial Sloan Kettering Commack - Limited Protocol Activities, Commack
  • Memorial Sloan Kettering Westchester - Limited Protocol Activities, Harrison
  • Memorial Sloan Kettering Cancer Center, New York
  • and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT04165772

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Recruiting
Ages 45 to 70 · All sexes · Updated Sep 2, 2026 · NCT05080673

Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • University of Rochester Medical Center, Rochester
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Sep 2, 2026 · NCT07292298

A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.

  • Weill Cornell Medical College, New York
  • Brooklyn Methodist Hospital - NewYork Presbyterian, New York
  • New York Presbyterian Hospital - Queens, New York
RecruitingPhase 2
Ages 18 to 90 · All sexes · Updated Jul 29, 2026 · NCT05024097

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

  • Roswell Park Cancer Institute, Buffalo
  • Memorial Sloan Kettering Commack, Commack
  • Memorial Sloan Kettering Westchester, Harrison
  • and 4 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 14, 2026 · NCT06205485

Integrated Cancer Repository for Cancer Research

  • C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
  • Faxton St. Luke's Healthcare, Mohawk Valley, Utica
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699

The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer

  • New York Presbyterian Brooklyn Methodist Hospital, Brooklyn
  • Weill Cornell Medical College, New York
  • New York Presbyterian Hospital - Queens, New York
Recruiting
Ages 18 to 90 · All sexes · Updated Jun 15, 2026 · NCT05943210

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

  • NYU Langone Medical Center, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT06051695

A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer

  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • and 1 more
Recruiting
Ages 18 and older · All sexes · Updated Jun 2, 2026 · NCT06637462

Brodalumab in the Treatment of Immune-Related Adverse Events

  • Columbia University Irving Medical Center, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated May 13, 2026 · NCT06673329

A Study of Tucatinib and Trastuzumab in People With Rectal Cancer

  • Memorial Sloan Kettering Cancer Center at Suffolk - Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 12, 2026 · NCT05672524

Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation

  • Memorial Sloan Kettering Cancer Center, New York
RecruitingObservational study
Ages 18 and older · All sexes · Updated Mar 12, 2026 · NCT04668872

Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)

  • Columbia University Irving Medical Center, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 25, 2026 · NCT07433673

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Buffalo
  • Massive Bio SYNERGY-AI site, Hempstead
  • Massive Bio SYNERGY-AI site, Manhasset
  • and 2 more
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

Feasibility of Non-Operative Management of Rectal Cancer in a Rural Population

  • Bassett Healthcare Network, Cooperstown
RecruitingObservational study
Ages 18 and older · All sexes · Updated Mar 7, 2023 · NCT04245683

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.